Northwestern University_Site number 124 — Chicago, Illinois

Northwestern University_Site number 124 is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Northwestern University_Site number 124 has participated in 1 clinical trials.

Therapeutic areas: Diffuse Cutaneous Systemic Sclerosis.

Sponsors: Kadmon, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northwestern University_Site number 124?

Northwestern University_Site number 124 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northwestern University_Site number 124 conducted?

Northwestern University_Site number 124 has 1 clinical trials on record. Their work covers Diffuse Cutaneous Systemic Sclerosis.

Is Northwestern University_Site number 124 accredited by Crixeo Health?

Northwestern University_Site number 124 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northwestern University_Site number 124?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.